06/16/2026
Eli Lilly’s Obesity Pill! There’s more competition in the fast-growing obesity treatment market now that Eli Lilly has introduced its once-daily GLP-1 pill. Lilly’s Foundayo (orforglipron) is the second pill approved by the U.S. Food and Drug Administration (FDA) to treat obesity. In December, the agency approved a pill form of the blockbuster drug Wegovy, manufactured by Novo Nordisk... https://bit.ly/4evtlhf
Eli Lilly’s Obesity PillThere’s more competition in the fast-growing obesity treatment market now that Eli Lilly has introduced its once-daily GLP-1 pill.Lilly’s Foundayo (orforglipron) is the second pill approved by the U.S.